AI adoption & safety
Evaluating an ambient AI scribe before clinical adoption
How an ambient AI documentation tool is evaluated for accuracy, safety, data protection and human factors before it is let near a consultation.
Illustrative example. This is a representative worked example of how we structure this kind of work — not a specific client engagement. It contains no client names, confidential information or achieved metrics. Real client work is confidential and shared only anonymised, with permission, under NDA.
The challenge
A clinical team wants to adopt an ambient AI scribe that listens to consultations and drafts notes. It promises to save time, but it also introduces new risks — mis-transcription, omitted safety-netting, and recording of confidential conversations. The organisation needs to decide, on evidence, whether and how to adopt it safely.
Approach
How the work is structured
The tool is assessed as what it is — a clinical documentation aid with patient-safety and data-protection implications — not just a productivity gadget.
- Accuracy & safety review. Assess how faithfully the draft reflects the encounter, and where errors or omissions could cause clinical harm.
- Data protection (DPIA). Complete a Data Protection Impact Assessment covering recording, processing, storage and third-party access.
- Human factors. Evaluate how clinicians review and correct drafts, because an over-trusted draft is itself a hazard.
- Adoption guardrails. Define the conditions, consent and review steps under which adoption is safe — or advise against it.
Result
What a good result looks like — and how it is measured
The deliverable is an evidence-based adoption decision with guardrails — including a clear willingness to recommend against adoption where the risks are not controllable.
- Documentation accuracy and clinically significant error rate against a reference
- A completed DPIA with identified risks and mitigations
- Human-factors findings on the review-and-correct step
- Defined consent, review and governance conditions for safe use
Transferability
Would this transfer to your setting?
Scribe performance varies by specialty, accent, environment and workflow. The example stresses that an evaluation in one setting does not license blanket rollout across others.
Answers
AI adoption & safety: frequently asked questions
Is this based on a specific product or client?
No. It is an illustrative worked example of how any ambient scribe would be evaluated. It names no product, client, patients or results.
Would you ever advise against adoption?
Yes. An honest evaluation has to be willing to conclude "not safe to adopt as-is" — otherwise the exercise is theatre. Stating limits plainly is the point.
Want proof relevant to your project?
Tell us your sector and challenge; we'll share matched, anonymised examples and references.